We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
Search results
From Proteopedia
You searched for Fulvestrant
There is no page with the exact title "Fulvestrant". The search results for "Fulvestrant" are displayed below. You can create a page titled Fulvestrant (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below 19 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Fulvestrant (42 bytes)
1: List of pages with the keyword Fulvestrant
Page text matches
- 4j03 (3,645 bytes)
2: ...of human soluble epoxide hydrolase complexed with fulvestrant==
14: ...s was tested for inhibition of sEH. We found that fulvestrant, an anticancer agent, is a potent (KI=26nM) compe...
16: Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.,Morisseau C, Pakhomova S, Hwang S... - Category:Fulvestrant (42 bytes)
1: List of pages with the keyword Fulvestrant - 8tdu (8,166 bytes)
16: ...n observed with alpelisib. Combining STX-478 with fulvestrant and/or cyclin-dependent kinase 4/6 inhibitors was... - 6chw (6,554 bytes)
14: ...and ERa(Y537S) breast cancer that was superior to fulvestrant. Lastly, H3B-5942 potency can be further improved... - 6p05 (4,361 bytes)
16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen... - Epoxide hydrolase 3D structures (6,177 bytes)
83: **[[4j03]] – hSEH + fulvestrant<br /> - 6sbo (6,299 bytes)
14: ...t cancer following antiestrogen therapy. However, fulvestrant shows poor pharmacokinetic properties in human, l... - 6wok (6,087 bytes)
14: ...-class" molecule with the same dual mechanisms as fulvestrant, but with significant oral exposure. Through lead... - 6zoq (6,046 bytes)
14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a... - 6zor (6,025 bytes)
14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a... - 6zos (6,039 bytes)
14: ...at showed a pharmacological profile comparable to fulvestrant in its ability to degrade ERalpha in both MCF-7 a... - 7jkw (4,219 bytes)
16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen... - 7jky (4,272 bytes)
16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen... - 7jkz (4,328 bytes)
16: ...ast cancer in monotherapy and in combination with fulvestrant. Importantly, at an equivalent dose in rats, thro...
18: ...ant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.,Li Y, Zhao J, Gutgesell LM, Shen... - 7te7 (6,234 bytes)
14: ...tor degrader fulvestrant. This advance shows that fulvestrant-like genomic activities can be achieved without a...
16: Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cance... - 8duk (6,362 bytes)
14: ...tor degrader fulvestrant. This advance shows that fulvestrant-like genomic activities can be achieved without a...
16: Unconventional isoquinoline-based SERMs elicit fulvestrant-like transcriptional programs in ER+ breast cance... - 8tgd (8,229 bytes)
16: ...n observed with alpelisib. Combining STX-478 with fulvestrant and/or cyclin-dependent kinase 4/6 inhibitors was... - 8xoi (4,112 bytes)
2: ... of GPR30-Gq complex structure in the presence of fulvestrant==
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
